Sera Prognostics Recognizes World Prematurity Day 2014
17 nov. 2014 10h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Nov. 17, 2014 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's healthcare company, today announced its recognition and support of World Prematurity Day on November 17 with a...
National Medal of Science Awardee Dr. Leroy Hood Joins Sera Prognostics as a Scientific Advisor
04 sept. 2013 12h58 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Sept. 4, 2013 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's healthcare company, today announced that Lee Hood, M.D., Ph.D., noted pioneer of systems biology and recent...
Sera Prognostics Completes Enrollment of Large Proteomic Assessment of Preterm Risk Clinical Study
21 août 2013 15h05 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Aug. 21, 2013 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's healthcare company, today announced that it has completed enrollment of 5,500 women into its landmark Proteomic...
Enrollment Exceeds 4,000 in Sera Prognostics' Preterm Birth Clinical Study
28 févr. 2013 09h45 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Utah, Feb. 28, 2013 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's health company, today announced that its Proteomic Assessment of Preterm Risk (PAPR) clinical study has now...
Sera Prognostics, Inc. Appoints Ilia Ichetovkin, Ph.D. as Vice President of Laboratory Operations
03 oct. 2012 16h46 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Oct. 3, 2012 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's health company developing diagnostic tests for early prediction of preterm birth and other pregnancy complications,...
Sera Prognostics, Inc. Appoints Sherree Frazier as Vice President of Sales & Marketing
02 juil. 2012 11h50 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, July 2, 2012 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's health company developing diagnostic tests for early prediction of preterm birth and other pregnancy complications,...
Sera Prognostics Appoints Jay Boniface, Ph.D., Vice President of Research & Development
09 janv. 2012 09h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Jan. 9, 2012 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's health company developing diagnostic tests for early prediction of preterm birth and other pregnancy complications,...
Sera Prognostics Secures $19.3 Million Series A Funding to Commercialize Preterm Birth Predictor; Appoints Gregory C. Critchfield, MD as Chief Executive Officer
15 nov. 2011 06h55 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, Nov. 15, 2011 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's health company developing diagnostic tests for early prediction of preterm birth and other pregnancy complications,...
Sera Prognostics' Co-Founders Recognized for Groundbreaking Approach to Discovering Novel Biomarker Predictors for Preterm Birth
24 mai 2011 11h00 HE
|
Sera Prognostics, Inc.
SALT LAKE CITY, May 24, 2011 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women's health company developing diagnostic tests for early prediction of preterm birth and other pregnancy complications,...
Sera Prognostics Appoints Two Industry Veterans to Lead the Commercialization of Its Preterm Birth Diagnostic Predictor
19 avr. 2011 11h00 HE
|
Sera Prognostics, Inc.
Former Myriad Genetic Labs President Gregory C. Critchfield, M.D. Tapped to Oversee Sera's Molecular Diagnostics Strategy
Mark J. Ostrowski Appointed to Lead Company as President and Chief...